Select your country and language
Singapore
Malaysia
Indonesia
Brunei

Dr. Chuah Yen Seong Benjamin

Dr. Chuah Yen Seong Benjamin

Designation: Specialist

Specialization:
Medical Oncology

Language spoken: English

Hospital Affiliation:
Gleneagles Hospital
Mount Elizabeth Hospital
Mount Elizabeth Novena Hospital
Mount Alvernia Hospital


Clinic Address:
OncoCare Cancer Centre (Mount Alvernia)
820 Thomson Road #08-53 Singapore 574623

Operating Hours: Mon-Fri: 08:30AM - 05:30PM
Sat: 08:30AM - 12:30PM

Tel: 62508160

Fax: 62508161

Clinic Address:
OncoCare Cancer Centre (Gleneagles)
6 Napier Road #02-17/18/19 Singapore 258499

Operating Hours:  Mon-Fri: 08:30AM - 05:30PM
Sat: 08:30AM - 12:30PM

Tel: 67337890

Fax: 67337891

Clinic Address:
OncoCare Cancer Centre (Mount Elizabeth)
3 Mount Elizabeth #17-05 Singapore 228510

Operating Hours:  Mon-Fri: 08:30AM - 05:30PM
Sat: 08:30AM - 12:30PM

Tel: 68365201

Fax: 68365202


Dr Benjamin Chuah was previously Consultant in the Department of Haematology-Oncology, National Cancer Institute Singapore, National University Hospital.

Graduating in medicine from Trinity College Dublin in 1998 where he was awarded the Professor Prize in Physic (Surgery) and the Arthur Ball Prize (2nd Place), Dr Chuah returned to Singapore and obtained his Membership of the Royal College of Physicians of the United Kingdom in 2002.

Prior to entering private practice, Dr Benjamin Chuah (patients often address him as Dr Ben Chuah) was actively involved in both post-graduate teaching and research. He was the Director for Postgraduate Medical Education (Medical Oncology) and was a Core Faculty for the Residency Program (Internal Medicine). He was also involved in clinical and translational research for many years and was the principal or co-investigator in international trials involving the use of novel and targeted therapy drugs for colorectal and pancreatic cancer.

Dr Ben Chuah’s subspecialty interest is in Gastrointestinal Cancers including oesophageal, gastric, biliary tract, pancreatic, liver (hepatocellular carcinoma), neuroendocrine cancers and colorectal cancers. As a clinical cancer specialist and researcher, his research work includes small cell gallbladder cancer with paraneoplastic hyponatremia, exploring the lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma, renal cell carcinoma (kidney cancer) with bony metastases and use of the chemotherapy drug, docetaxel (Taxotere) with or without ketoconazole in breast cancer. He has published on screening in colorectal cancer and was involved in a randomized, phase 2 study of ganitumab or conatumumab in combination with FOLFIRI (5-FU, leucovorin, irinotecan) for second-line treatment of mutant KRAS metastatic colorectal cancer.

Awards and Publications
Awarded the Professor's Prize in Physic (Surgery) 1998, Arthur Ball Prize (2nd place) 1998, NUH Innovative Grant 2007, the Kobayashi Foundation Award 2010 and NUH Postgraduate Teaching Excellence Award 2011.

He was awarded the NUH Innovative Grant for research in warfarin pharmacogenomics and was also honoured with the inaugural Kobayashi Foundation Award for work done on serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy. His research work has lead to several 1st author publications in high impact medical and oncology journals including Gastroenterology, GUT and Annals of Oncology.

Back to top
Need help?
For product enquiries
For customer service
Get Help
Contact Us
Make a claim
Buy General Insurance
Great Eastern Holdings Ltd | Great Eastern Life Assurance Co Ltd | Great Eastern General Insurance Ltd
Great Eastern Holdings Ltd | Great Eastern Life Assurance Co Ltd | Great Eastern General Insurance Ltd